BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3930265)

  • 1. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.
    Araki H; Kawashima K; Uchiyama Y; Aihara H
    Eur J Pharmacol; 1985 Jul; 113(3):313-8. PubMed ID: 3930265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdaloid catecholaminergic mechanisms involved in suppressive effects of electroconvulsive shock on duration of immobility in rats forced to swim.
    Kawashima K; Araki H; Uchiyama Y; Aihara H
    Eur J Pharmacol; 1987 Sep; 141(1):1-6. PubMed ID: 3117575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ACTH on the imipramine- and desipramine-induced decrease in duration of immobility time as measured in a rat forced swimming test.
    Takamori K; Yoshida S; Okuyama S
    Life Sci; 2001 Sep; 69(16):1891-6. PubMed ID: 11693269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats.
    Nakagawa Y; Ishima T; Takashima T
    Brain Res; 1998 Mar; 786(1-2):189-93. PubMed ID: 9555008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of local injection of 5,7-DHT and 6-OH-DA into the neocortex on learning and exploratory behavior of rats in the open field.
    Ismailova KhY; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV; Gromova EA
    Neurosci Behav Physiol; 1990; 20(6):493-9. PubMed ID: 2128948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
    Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.
    Connor TJ; Kelliher P; Shen Y; Harkin A; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 2000 Apr; 65(4):591-7. PubMed ID: 10764911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic localization of [3H]-imipramine binding sites: association with serotonergic neurons.
    Dawson TM; Wamsley JK
    Brain Res Bull; 1983 Sep; 11(3):325-34. PubMed ID: 6416614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test.
    Kitamura Y; Araki H; Gomita Y
    Pharmacol Biochem Behav; 2002; 71(1-2):63-9. PubMed ID: 11812508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1990 Mar; 178(1):129-33. PubMed ID: 2158897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobility-reducing effects of antidepressants in a genetic animal model of depression.
    Schiller GD; Pucilowski O; Wienicke C; Overstreet DH
    Brain Res Bull; 1992 May; 28(5):821-3. PubMed ID: 1617465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
    Martin-Iverson MT; Leclere JF; Fibiger HC
    Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picrotoxin changes the effects of imipramine and desipramine in rats in the forced swimming test.
    Fernández-Teruel A; Escorihuela RM; Boix F; Tobeña A
    Eur J Pharmacol; 1990 May; 181(1-2):35-41. PubMed ID: 2387320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of minaprine and sulpiride injected into the amygdaloid nucleus on the duration of immobility in rats forced to swim.
    Kawashima K; Araki H; Aihara H; Otomo S
    Jpn J Pharmacol; 1990 Jul; 53(3):411-3. PubMed ID: 2391769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test.
    Cervo L; Grignaschi G; Rossi C; Samanin R
    Eur J Pharmacol; 1991 Apr; 196(3):217-22. PubMed ID: 1909956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of the involvement of dopamine in the analgesic effect of nefopam.
    Esposito E; Romandini S; Merlo-Pich E; Mennini T; Samanin R
    Eur J Pharmacol; 1986 Sep; 128(3):157-64. PubMed ID: 3098570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test.
    Kitada Y; Miyauchi T; Kanazawa Y; Nakamichi H; Satoh S
    Neuropharmacology; 1983 Sep; 22(9):1055-60. PubMed ID: 6314168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.